Anemia and iron deficiency in heart failure: current concepts and emerging therapies
IS Anand, P Gupta - Circulation, 2018 - Am Heart Assoc
Anemia and iron deficiency are important and common comorbidities that often coexist in
patients with heart failure. Both conditions, together or independently, are associated with …
patients with heart failure. Both conditions, together or independently, are associated with …
Anemia and chronic heart failure: implications and treatment options
IS Anand - Journal of the American College of Cardiology, 2008 - jacc.org
Anemia is a common comorbidity in patients with heart failure and is associated with worse
long-term outcomes. Although the cause of anemia in heart failure is unclear, the weight of …
long-term outcomes. Although the cause of anemia in heart failure is unclear, the weight of …
Normalization of hemoglobin level in patients with chronic kidney disease and anemia
TB Drüeke, F Locatelli, N Clyne… - … England Journal of …, 2006 - Mass Medical Soc
Background Whether correction of anemia in patients with stage 3 or 4 chronic kidney
disease improves cardiovascular outcomes is not established. Methods We randomly …
disease improves cardiovascular outcomes is not established. Methods We randomly …
[HTML][HTML] Iron treatment normalizes cognitive functioning in young women
LE Murray-Kolb, JL Beard - The American journal of clinical nutrition, 2007 - Elsevier
Background: Evidence suggests that brain iron deficiency at any time in life may disrupt
metabolic processes and subsequently change cognitive and behavioral functioning …
metabolic processes and subsequently change cognitive and behavioral functioning …
Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients
DL Regidor, JD Kopple, CP Kovesdy… - Journal of the …, 2006 - journals.lww.com
Although treating anemia of chronic kidney disease by erythropoiesis-stimulating agents
(ESA) may improve survival, most studies have examined associations between baseline …
(ESA) may improve survival, most studies have examined associations between baseline …
Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease
PS Parfrey, RN Foley, BH Wittreich… - Journal of the …, 2005 - journals.lww.com
It is unclear whether physiologic hemoglobin targets lead to cardiac benefit in incident
hemodialysis patients without symptomatic heart disease and left ventricular dilation. In this …
hemodialysis patients without symptomatic heart disease and left ventricular dilation. In this …
Quality of life in patients with chronic kidney disease: focus on end-stage renal disease treated with hemodialysis
PL Kimmel, SS Patel - Seminars in nephrology, 2006 - Elsevier
The proper measures for assessing quality of life (QOL) in patients with chronic kidney
disease (CKD) remain unclear. QOL measures are subjective or objective, functional or …
disease (CKD) remain unclear. QOL measures are subjective or objective, functional or …
A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre‐dialysis and dialysis patients
H Furuland, T Linde, J Ahlmén… - Nephrology Dialysis …, 2003 - academic.oup.com
Background. Partial correction of renal anaemia with erythropoietin improves quality of life
(QoL). We aimed to examine if normalization of haemoglobin with epoetin alfa in pre …
(QoL). We aimed to examine if normalization of haemoglobin with epoetin alfa in pre …
[HTML][HTML] The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients
N Ofsthun, J Labrecque, E Lacson, M Keen… - Kidney international, 2003 - Elsevier
The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis
patients. Background The introduction of recombinant human erythropoietin for the treatment …
patients. Background The introduction of recombinant human erythropoietin for the treatment …
Epidemiology of cardiovascular risk in patients with chronic kidney disease
F Locatelli, P Pozzoni, F Tentori… - Nephrology Dialysis …, 2003 - academic.oup.com
Background. Chronic kidney disease (CKD) patients are highly prone to cardiovascular
disease for a number of reasons. At the time of starting renal replacement treatment, their …
disease for a number of reasons. At the time of starting renal replacement treatment, their …